Shelton Capital Management bought a new stake in shares of Magellan Health Inc (NASDAQ:MGLN) in the 4th quarter, HoldingsChannel.com reports. The firm bought 2,121 shares of the company’s stock, valued at approximately $205,000.

Other hedge funds have also recently made changes to their positions in the company. Ameritas Investment Partners Inc. boosted its position in shares of Magellan Health by 6.1% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,087 shares of the company’s stock valued at $152,000 after purchasing an additional 120 shares during the period. Advisory Services Network LLC acquired a new position in shares of Magellan Health in the 2nd quarter valued at $165,000. HighTower Advisors LLC acquired a new position in shares of Magellan Health in the 2nd quarter valued at $210,000. Amalgamated Bank boosted its position in shares of Magellan Health by 5.1% in the 2nd quarter. Amalgamated Bank now owns 3,265 shares of the company’s stock valued at $238,000 after purchasing an additional 159 shares during the period. Finally, Parametrica Management Ltd acquired a new position in shares of Magellan Health in the 3rd quarter valued at $244,000. 94.98% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts recently weighed in on MGLN shares. ValuEngine upgraded Magellan Health from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. BidaskClub lowered Magellan Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 19th. KeyCorp set a $105.00 price target on Magellan Health and gave the company a “buy” rating in a research report on Friday, December 1st. Zacks Investment Research lowered Magellan Health from a “buy” rating to a “hold” rating in a research report on Wednesday, February 7th. Finally, Raymond James Financial reiterated a “hold” rating on shares of Magellan Health in a research report on Saturday, December 2nd. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $96.00.

Magellan Health Inc (MGLN) opened at $93.45 on Monday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.28 and a quick ratio of 2.21. Magellan Health Inc has a 1 year low of $64.05 and a 1 year high of $102.70. The firm has a market capitalization of $2,246.75, a price-to-earnings ratio of 21.29, a P/E/G ratio of 1.10 and a beta of 0.52.

In related news, CEO Mostafa Kamal sold 2,180 shares of the stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $92.00, for a total value of $200,560.00. Following the completion of the sale, the chief executive officer now directly owns 2,180 shares of the company’s stock, valued at approximately $200,560. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Daniel N. Gregoire sold 8,275 shares of the stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $89.08, for a total value of $737,137.00. Following the completion of the sale, the general counsel now directly owns 16,690 shares of the company’s stock, valued at $1,486,745.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 113,953 shares of company stock valued at $10,797,505. Company insiders own 5.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Shelton Capital Management Buys Shares of 2,121 Magellan Health Inc (MGLN)” was first reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://theolympiareport.com/2018/02/12/shelton-capital-management-buys-shares-of-2121-magellan-health-inc-mgln.html.

About Magellan Health

Magellan Health, Inc is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC).

Want to see what other hedge funds are holding MGLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Magellan Health Inc (NASDAQ:MGLN).

Institutional Ownership by Quarter for Magellan Health (NASDAQ:MGLN)

Receive News & Ratings for Magellan Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health and related companies with MarketBeat.com's FREE daily email newsletter.